Top Markets
Coin of the day
Pardes Biosciences, Inc. Pardes Biosciences, Inc.

Pardes Biosciences, Inc.

PRDS
Rangering i aksjer #20768
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated... Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, developing, and marketing groundbreaking treatments. The company's core objective is to improve outcomes for patients battling life-threatening illnesses. Its primary investigational therapy, PBI-0451, is currently progressing through clinical development with the aim of both treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and their related health issues. Established in 2020, Pardes Biosciences maintains its corporate headquarters in Carlsbad, California.
Aksjekurs
$2.16
Sist synkronisert: 2023-09-08
Markedsverdi
$122.36M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Pardes Biosciences, Inc. (PRDS)

Kategori

Pris PRDS pris med markedsverdi på B
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
PRDS
$2.16
Markedsverdi av Pardes Biosciences, Inc.(PRDS)
Markedsverdi: $122.36M
Per August 2026 har Pardes Biosciences, Inc. en markedsverdi på $122.36M. Dette gjør Pardes Biosciences, Inc. til det 20768th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Pardes Biosciences, Inc. fra 2021 til 2026
PRDS sammenlignet med topp 5 mest populære stocks
Pris på PRDS Eiendel B Markedsverdi for B Resultater
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$91,999.27 $122.36M
$5.211T +4,259,125.30%
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$80,266.30 $122.36M
$4.547T +3,715,932.38%
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$73,482.56 $122.36M
$4.162T +3,401,870.44%
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$63,425.58 $122.36M
$3.593T +2,936,269.59%
Pardes Biosciences, Inc. Pardes Biosciences, Inc.
$49,303.85 $122.36M
$2.793T +2,282,485.64%